ELL2 and Miyoshi myopathy: To examine the relationship between rs6877329 genotype and ELL2 expression on patient outcome, defined by overall survival (OS) and progression-free survival (PFS), we made use of data from the UK MRC MyIX and MyXI trials and the German GMMG trial, totaling 505 MM patients with expression data and 2,553 patients with genotype data.